Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
365
-
Total 13F shares, excl. options
-
43.5M
-
Shares change
-
+113K
-
Total reported value, excl. options
-
$4.87B
-
Value change
-
-$69.3K
-
Put/Call ratio
-
1.21
-
Number of buys
-
157
-
Number of sells
-
-204
-
Price
-
$112.36
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2018
434 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q1 2018.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 365 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.5M shares
of 44.8M outstanding shares and own 97.02% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.91M shares), FMR LLC (3.83M shares), VANGUARD GROUP INC (3.6M shares), STATE STREET CORP (2.09M shares), AQR CAPITAL MANAGEMENT LLC (1.82M shares), Palo Alto Investors LP (1.62M shares), RENAISSANCE TECHNOLOGIES LLC (1.53M shares), ACADIAN ASSET MANAGEMENT LLC (1.22M shares), GOLDMAN SACHS GROUP INC (1.02M shares), and Old Mutual Global Investors (UK) Ltd. (962K shares).
This table shows the top 365 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.